DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 205 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,772 | +19.7% | 797 | +4.7% | 0.00% | 0.0% |
| Q2 2023 | $9,832 | +37.9% | 761 | +4.7% | 0.00% | 0.0% |
| Q1 2023 | $7,132 | -12.4% | 727 | -5.0% | 0.00% | 0.0% |
| Q4 2022 | $8,140 | +1.8% | 765 | -5.8% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | -11.1% | 812 | +11.7% | 0.00% | 0.0% |
| Q2 2022 | $9,000 | +12.5% | 727 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | -20.0% | 727 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $10,000 | -28.6% | 727 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $14,000 | +100.0% | 727 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $7,000 | 0.0% | 727 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | +133.3% | 727 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $3,000 | 0.0% | 727 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | -50.0% | 727 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $6,000 | +500.0% | 727 | +247.8% | 0.00% | – |
| Q1 2020 | $1,000 | – | 209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |